Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Acorda Therapeutics

Acorda Therapeutics
1995 FOUNDED
PUBLIC STATUS
401-500 EMPLOYEES
ACOR STOCK SYMBOL
7 INVESTMENTS
$1.69 SHARE PRICE (As of Tuesday Closing)
Description

Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders.Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 420 Saw Mill River Road
  • Ardsley, NY 10502
  • United States

+1 (914) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Acorda Therapeutics’s full profile, request a free trial.

Acorda Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.49 - $17.57 $81.2M $1.72 -$6.93 1.66M 48M

Acorda Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 198,370 596,173 1,116,642 1,037,254
Revenue 211,063 471,433 588,287 519,601
EBITDA (348,378) 49,981 (210,123) (4,498)
Net Income (329,031) 33,682 (223,359) (34,618)
Total Assets 879,913 1,299,666 1,197,969 1,342,335
Total Debt 358,470 337,051 319,535 316,122
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Acorda Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Acorda Therapeutics‘s full profile, request access.

Request full access to PitchBook

Acorda Therapeutics Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pluristem Therapeutics Corporation Haifa, Israel 000 000.00 000000000
00000000000 Formerly VC-backed Malvern, PA 000 00000 00000000 00000
000000000000 Venture Capital-Backed Clarksville, MD 0 00.000 0000000000 0 00.000
000000 00000000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
000000000 Formerly VC-backed Rehovot, Israel 00 000.00 000000&0 000.00
To view this company’s complete list of competitors, request access »

Acorda Therapeutics Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000000 18-Apr-2016 000000000000000000 00000 Biotechnology 000 00000 00
0000000 0000000000 23-Oct-2014 000000000000000000 00000 Drug Delivery 000 00000 00
000000000 10-Jul-2013 000000000000000000 Pharmaceuticals
0000000 09-Jul-2013 000000000000000000 Biotechnology 000 00000 00
Neuronex 21-Dec-2012 Merger/Acquisition 000.00 Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

Acorda Therapeutics Subsidiaries (1)

Company Name Industry Location Founded
0000000 Biotechnology Ardsley, NY
To view this company’s complete subsidiary history, request access »

Acorda Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Acorda Therapeutics‘s full profile, request access.

Request full access to PitchBook

Acorda Therapeutics Executive Team (16)

Name Title Board
Seat
Contact
Info
Ron Cohen MD Chief Executive Officer & Board Member
Jane Wasman General Counsel & President
David Lawrence Chief Accounting Officer & Executive
Lauren Sabella Executive
Denise Duca Executive Vice President, Human Resources

9 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

Acorda Therapeutics Board Members (8)

Name Representing Role Since Contact
Info
Barry Greene Self Board Member 000 0000
John Kelley Acorda Therapeutics Board Member 000 0000
Lorin Randall Acorda Therapeutics Board Member 000 0000
Peder Jensen MD Acorda Therapeutics Board Member 000 0000
Ron Cohen MD Acorda Therapeutics Chief Executive Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 8 board members. Get the full list »